Peng Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Peng Li has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Amit Kumar Singh
Department of Immunology and Microbial Disease, Albany Medical College , Albany, NY
1 shared publication - Roy Curtiss
Department of Infectious Diseases & Immunology, College of Veterinary Medicine, University of Florida, Gainesville, FL 32608, USA
1 shared publication - Wei Sun
Department of Immunology and Microbial Disease, Albany Medical College, Albany, NY, 12208, USA
1 shared publication Xiangmin Zhang
Department of Pharmaceutical Sciences, Eugene Applebaum College of Pharmacy/Health Sciences, Wayne State University, Detroit, MI 48201
1 shared publication- Xiuran Wang
Engineering Research Center of Bioreactor and Drug Development, Ministry of Education, College of Life Sciences, Jilin Agricultural University, Changchun, China
1 shared publication - Ziqiang Guan
Department of Biochemistry, Duke University School of Medicine, Durham, USA
1 shared publication
Latest Publications
- Open Access
- 11 March 2022
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 119 (11)
RemodelingYersinia pseudotuberculosisto generate a highly immunogenic outer membrane vesicle vaccine against pneumonic plague
Significance: Yersinia pestis, the etiologic agent of plague, has been responsible for high mortality in several epidemics throughout human history. This plague bacillus has been used as a biological weapon during human history and is currently one of the deadliest biological threats. Currently, no licensed plague vaccines are available in the Western world. Since an array of immunogens are enclosed in outer membrane vesicles (OMVs), immune responses elicited by OMVs against a diverse range of antigens may reduce the likelihood of antigen circumvention. Therefore, self-adjuvanting OMVs from a remodeledYersinia pseudotuberculosisstrain as a type of plague vaccine could diversify prophylactic choices and solve current vaccine limitations.
- 11 March 2022
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 119 (11)
Open AccessRemodelingYersinia pseudotuberculosisto generate a highly immunogenic outer membrane vesicle vaccine against pneumonic plague
Significance: Yersinia pestis, the etiologic agent of plague, has been responsible for high mortality in several epidemics throughout human history. This plague bacillus has been used as a biological weapon during human history and is currently one of the deadliest biological threats. Currently, no licensed plague vaccines are available in the Western world. Since an array of immunogens are enclosed in outer membrane vesicles (OMVs), immune responses elicited by OMVs against a diverse range of antigens may reduce the likelihood of antigen circumvention. Therefore, self-adjuvanting OMVs from a remodeledYersinia pseudotuberculosisstrain as a type of plague vaccine could diversify prophylactic choices and solve current vaccine limitations.